Roche Pharma R&D (pRED)
Our scientists are amongst the best in the industry, discovering and translating cutting-edge science in the pursuit of delivering life-changing benefits to patients.
We continue to be driven by our long-term aim to deliver these medical advances that provide greater benefits to patients, and at the same time, reduce the healthcare burden on society.
pRED's research spans across 7 disease areas:
pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day. Find out some examples of areas where pRED is leading the field.
Roche pRED publications
Roche is an innovation company pioneering the future of healthcare, science and R&D.
Revolutionary discoveries in science are truly enabled when we have open minds and ears to share and collaborate.
Meet the pRED scientists
At pRED, it’s not the easy questions that excite us, it’s the biggest challenges in healthcare. That’s why we’ve set ourselves big goals to discover treatments that provide greater benefits for patients at a lower cost to society. This means having the expertise, resources and latest technologies at our fingertips, within an organisation that nurtures innovation built on curiosity and responsibility.
[Person 1] I study molecules that one day may transform the lives of people with cancer.
[Person 2] I reactivate the body's own ability to fight back against cancer using the immune system.
[Person 3 and 4] We look to find tumours' vulnerabilities, and we develop molecules that target those weaknesses directly.
[Person 5 and 6] We develop cutting-edge technologies that provide early valuable insights into the way our molecules work.
[Person 7] I analyse tissues to understand the nature of tumours and how to beat them.
[Person 8] I help transform our most promising molecules into drugs through elaborate technical design and development.
[Person 9] I generate scientific imaging data to see the impact of our molecules on the tumours.
[Person 10] I study the molecules' activities in early clinical trials to see how they can help patients fight their cancers.
[Person 11] I ensure our scientific discoveries meet all criteria to enter clinical testing with patients.
[Person 12] I ensure we're bringing all these exciting innovations from the lab to the clinic as quickly and as safely as possible.
[All]
Together, we are taking a stand.
Taking a stand.
Taking a stand.
Taking a stand.
Taking a stand.
Together, we are taking a stand against cancer.